<VariationArchive VariationID="5636" VariationName="NM_012203.2(GRHPR):c.103del (p.Asp35fs)" VariationType="Deletion" Accession="VCV000005636" Version="36" RecordType="classified" NumberOfSubmissions="16" NumberOfSubmitters="16" DateLastUpdated="2024-06-17" DateCreated="2013-05-03" MostRecentSubmission="2024-06-17">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="20675" VariationID="5636">
      <GeneList>
        <Gene Symbol="GRHPR" FullName="glyoxylate and hydroxypyruvate reductase" GeneID="9380" HGNC_ID="HGNC:4570" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>9p13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="37422435" stop="37439494" display_start="37422435" display_stop="37439494" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="37422706" stop="37436985" display_start="37422706" display_stop="37436985" Strand="+" />
          </Location>
          <OMIM>604296</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_012203.2(GRHPR):c.103del (p.Asp35fs)</Name>
      <CanonicalSPDI>NC_000009.12:37424861:GGG:GG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>9p13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="9" Accession="NC_000009.12" start="37424862" stop="37424862" display_start="37424862" display_stop="37424862" variantLength="1" positionVCF="37424861" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="9" Accession="NC_000009.11" start="37424859" stop="37424859" display_start="37424859" display_stop="37424859" variantLength="1" positionVCF="37424858" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>D35fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.11" sequenceAccession="NC_000009" sequenceVersion="11" change="g.37424861del" Assembly="GRCh37">
            <Expression>NC_000009.11:g.37424861del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000009.12" sequenceAccession="NC_000009" sequenceVersion="12" change="g.37424864del" Assembly="GRCh38">
            <Expression>NC_000009.12:g.37424864del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008135.1" sequenceAccession="NG_008135" sequenceVersion="1" change="g.7155del">
            <Expression>NG_008135.1:g.7155del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012203.2" sequenceAccession="NM_012203" sequenceVersion="2" change="c.103del" MANESelect="true">
            <Expression>NM_012203.2:c.103del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_036335.1" sequenceAccession="NP_036335" sequenceVersion="1" change="p.Asp35fs">
            <Expression>NP_036335.1:p.Asp35fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012203.1" sequenceAccession="NM_012203" sequenceVersion="1" change="c.103del">
            <Expression>NM_012203.1:c.103del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_012203.2" sequenceAccession="NM_012203" sequenceVersion="2" change="c.103delG" MANESelect="true">
            <Expression>NM_012203.2:c.103delG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA340440" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="604296.0001" DB="OMIM" />
        <XRef Type="rs" ID="80356708" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_012203.2(GRHPR):c.103del (p.Asp35fs) AND Primary hyperoxaluria, type II" Accession="RCV000005990" Version="33">
        <ClassifiedConditionList TraitSetID="1588">
          <ClassifiedCondition DB="MedGen" ID="C0268165">Primary hyperoxaluria, type II</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-30" SubmissionCount="12">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_012203.2(GRHPR):c.103del (p.Asp35fs) AND not provided" Accession="RCV000724161" Version="12">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-01-25" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_012203.2(GRHPR):c.103del (p.Asp35fs) AND multiple conditions" Accession="RCV000662321" Version="2">
        <ClassifiedConditionList TraitSetID="43804">
          <ClassifiedCondition DB="MedGen" ID="C0027709">Nephrocalcinosis</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0392525">Nephrolithiasis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2017-09-08" SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-30" NumberOfSubmissions="16" NumberOfSubmitters="16" DateCreated="2013-05-03" MostRecentSubmission="2024-06-17">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10484776</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11030416</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12185464</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">14635115</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15327387</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18560364</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24116921</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25644115</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">28893421</ID>
        </Citation>
        <Citation Type="general">
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=GRHPR</URL>
        </Citation>
        <Citation Type="general">
          <URL>http://www.uclh.nhs.uk/OurServices/ServiceA-Z/PATH/PATHBIOMED/CBIO/Documents/GRHPR%20mutation%20database.pdf</URL>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301742</ID>
          <ID Source="BookShelf">NBK2692</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1588" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2365" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">OXALOSIS II</ElementValue>
                <XRef Type="MIM" ID="260000" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Primary hyperoxaluria type 2</ElementValue>
                <XRef ID="MONDO:0009824" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Primary hyperoxaluria, type II</ElementValue>
                <XRef ID="Primary+hyperoxaluria+type+2/5948" DB="Genetic Alliance" />
                <XRef ID="40951006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oxalosis 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glyoxylate reductase/hydroxypyruvate reductase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glyceric aciduria</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">D-glycerate dehydrogenase deficiency</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PH2</ElementValue>
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">HP2</ElementValue>
                <XRef Type="MIM" ID="260000" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Primary hyperoxaluria type 2 (PH2), caused by deficiency of the enzyme glyoxylate reductase/hydroxypyruvate reductase (GR/HPR), is characterized by recurrent nephrolithiasis (deposition of calcium oxalate in the renal pelvis/urinary tract), nephrocalcinosis (deposition of calcium oxalate in the renal parenchyma), and end-stage renal disease (ESRD). After ESRD, oxalosis (widespread tissue deposition of calcium oxalate) usually develops. Symptom onset is typically in childhood.</Attribute>
                <XRef ID="NBK2692" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2836" />
                <XRef ID="2836" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000561372" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507682" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301742</ID>
                <ID Source="BookShelf">NBK2692</ID>
              </Citation>
              <XRef ID="416" DB="Orphanet" />
              <XRef ID="93599" DB="Orphanet" />
              <XRef ID="C0268165" DB="MedGen" />
              <XRef ID="MONDO:0009824" DB="MONDO" />
              <XRef Type="MIM" ID="260000" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="43804" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="21434" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hypercalcemic nephropathy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nephrocalcinosis</ElementValue>
                <XRef ID="HP:0000121" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0001567" DB="MONDO" />
                <XRef ID="48638002" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7177" />
                <XRef ID="7177" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="C0027709" DB="MedGen" />
              <XRef ID="MONDO:0001567" DB="MONDO" />
              <XRef Type="primary" ID="HP:0000121" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="21922" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Nephrolithiasis</ElementValue>
                <XRef ID="HP:0000787" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0008171" DB="MONDO" />
              </Name>
              <XRef ID="C0392525" DB="MedGen" />
              <XRef ID="MONDO:0008171" DB="MONDO" />
              <XRef Type="primary" ID="HP:0000787" DB="Human Phenotype Ontology" />
              <XRef Type="secondary" ID="HP:0000102" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26172" SubmissionDate="2014-12-12" DateLastUpdated="2014-12-16" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604296.0001_HYPEROXALURIA, PRIMARY, TYPE II" title="GRHPR, 1-BP DEL, 103G _HYPEROXALURIA, PRIMARY, TYPE II" />
        <ClinVarAccession Accession="SCV000026172" DateUpdated="2014-12-16" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 pairs of sibs from 2 unrelated families with type II primary hyperoxaluria (HP2; 260000), Cramer et al. (1999) identified deletion of the first nucleotide (G) of codon 35 (103G) of the GRHPR gene, resulting in a frameshift beginning at codon 35 and predicted to result in a truncated protein of 44 amino acids. All 4 patients were homozygous for this mutation.</Attribute>
              <Citation>
                <ID Source="PubMed">10484776</ID>
              </Citation>
              <XRef DB="OMIM" ID="260000" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The c.103delG mutation in exon 2 results in a frameshift and premature termination (Asp35ThrfsTer44). It is the most common GRHPR mutation, occurring in approximately 40% of published cases, and is found only in Caucasian individuals of northern European or American origin (review by Takayama et al., 2014).</Attribute>
              <Citation>
                <ID Source="PubMed">24116921</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRHPR" />
          </GeneList>
          <Name>GRHPR, 1-BP DEL, 103G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 103G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604296.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HYPEROXALURIA, PRIMARY, TYPE II</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="443561" SubmissionDate="2014-11-27" DateLastUpdated="2015-07-23" DateCreated="2015-07-23">
        <ClinVarSubmissionID localKey="NM_012203.1:c.103delG" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000239809" DateUpdated="2015-07-23" DateCreated="2015-07-23" Type="SCV" Version="1" SubmitterName="Clinical Biochemistry Laboratory, Health Services Laboratory" OrgID="118451" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2014-11-27">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>research</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Citation>
              <ID Source="PubMed">11030416</ID>
            </Citation>
            <Citation>
              <ID Source="PubMed">14635115</ID>
            </Citation>
            <Citation>
              <URL>http://www.uclh.nhs.uk/OurServices/ServiceA-Z/PATH/PATHBIOMED/CBIO/Documents/GRHPR%20mutation%20database.pdf</URL>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRHPR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012203.1:c.103delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Primary hyperoxaluria, type II</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="260000" Type="MIM" />
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1530270" SubmissionDate="2017-11-27" DateLastUpdated="2018-07-14" DateCreated="2018-07-14">
        <ClinVarSubmissionID localKey="NM_012203.1:c.103delG|Nephrolithiasis;Nephrocalcinosis" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000784653" DateUpdated="2018-07-14" DateCreated="2018-07-14" Type="SCV" Version="1" SubmitterName="Yale Center for Mendelian Genomics, Yale University" OrgID="506150" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-09-08">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">28893421</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="CompoundHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012203.1:c.103delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Finding">
            <Name>
              <ElementValue Type="Preferred">Nephrolithiasis</ElementValue>
            </Name>
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Nephrocalcinosis</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB3260470</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="645141" SubmissionDate="2018-09-19" DateLastUpdated="2018-12-15" DateCreated="2016-12-06">
        <ClinVarSubmissionID localKey="21968_000000" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000331674" DateUpdated="2018-12-15" DateCreated="2016-12-06" Type="SCV" Version="4" SubmitterName="Eurofins Ntd Llc (ga)" OrgID="500060" OrganizationCategory="laboratory" OrgAbbreviation="EGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-05-02">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">14635115</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">EGL Classification Definitions 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/ahdynye1/egl_classification_definitions_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
              <Gender>mixed</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="2" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="2" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRHPR" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="9" alternateAllele="-" referenceAllele="G" start="37424861" stop="37424861" variantLength="1" />
            <GeneLocation>NM_012203.1:Ex2</GeneLocation>
          </Location>
          <XRefList>
            <XRef DB="HGMD" ID="CD992266" />
            <XRef DB="dbSNP" ID="80356708" Type="rsNumber" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation>
          <URL>http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=GRHPR</URL>
        </Citation>
        <SubmissionNameList>
          <SubmissionName>SUB4534263</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1796096" SubmissionDate="2019-04-24" DateLastUpdated="2019-05-31" DateCreated="2019-05-31">
        <ClinVarSubmissionID localKey="NM_012203.1:c.103delG|MedGen:C0268165" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000919475" DateUpdated="2019-05-31" DateCreated="2019-05-31" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-11-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15327387</ID>
          </Citation>
          <Comment>Variant summary: The GRHPR c.103delG (p.Asp35ThrfsX11) variant results in a premature termination codon, predicted to cause a truncated or absent GRHPR protein due to nonsense mediated decay, which are commonly known mechanisms for disease. This variant was found in 62/274980 control chromosomes (gnomAD) at a frequency of 0.0002255, which does not exceed the estimated maximal expected allele frequency of a pathogenic GRHPR variant (0.0014434). Multiple publications have cited the variant in affected homozygote and compound heterozygote pts. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. Taken together, this variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRHPR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012203.1:c.103delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Primary hyperoxaluria, type II</ElementValue>
            </Name>
            <XRef DB="MedGen" ID="C0268165" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5494893</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1394017" SubmissionDate="2019-03-21" DateLastUpdated="2018-04-09" DateCreated="2018-04-09">
        <ClinVarSubmissionID localKey="73085132|Orphanet:ORPHA93599" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000712910" DateUpdated="2018-04-09" DateCreated="2018-04-09" Type="SCV" Version="1" SubmitterName="Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine" OrgID="21766" OrganizationCategory="laboratory" OrgAbbreviation="LMM" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2017-03-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10484776</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15327387</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14635115</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12185464</ID>
          </Citation>
          <Comment>The p.Asp35ThrfsX11 (NM_012203.1 c.103delG) variant in GRHPR has been reported i n at least 15 homozygous and 1 compound heterozygous individuals with primary hy peroxaluria type II, and segregated in two homozygous affected siblings from two families (Cramer 1999, Webster 2000, Johnson 2002, Cregeen 2003, Rumsby 2003). It is the most common pathogenic variant identified in Caucasian patients with t his disease (Takayama 2014). This variant has also been reported as pathogenic i n ClinVar (Variation ID#5636). The p.Asp35ThrfsX11 variant has been identified i n 21/64772 of European chromosomes by the Exome Aggregation Consortium (ExAC, ht tp://exac.broadinstitute.org; dbSNP rs80356708), a frequency low enough to be co nsistent with carrier frequency. This variant is predicted to cause a frameshift , which alters the protein?s amino acid sequence beginning at position 35 and le ads to a premature termination codon 11 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. Biallelic loss of fu nction of function of the GRHPR gene is an established disease mechanism in prim ary hyperoxaluria type II. In summary, the p.Asp35ThrfsX11 variant meets criteri a to be classified as pathogenic for primary hyperoxaluria type II in an autosom al recessive manner based upon its biallelic occurrence in patients with this di sease and predicted impact on protein function.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LMM Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">24033266</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>not provided</AffectedStatus>
              <FamilyData NumFamiliesWithVariant="1" />
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRHPR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_012203.1:EXON 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>NM_012203.1:c.103delG</Name>
            <Name>p.Asp35ThrfsX11</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.37424861delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="Orphanet" ID="ORPHA93599" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5348977</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="41222" SubmissionDate="2022-06-16" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_012203.1:c.103delG|OMIM:260000" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000041222" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="4" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK2692</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012203.1:c.103delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268165" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11621967</SubmissionName>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7327318" SubmissionDate="2023-04-26" DateLastUpdated="2023-04-30" DateCreated="2023-04-30">
        <ClinVarSubmissionID localKey="GDXSV:268741" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV003919446" DateUpdated="2023-04-30" DateCreated="2023-04-30" Type="SCV" Version="1" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-20">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 16208537, 24116921, 18560364, 10484776, 31980526, 21228398, 14635115, 15327387, 11030416, 25644115, 28893421, 30609409, 31685312, 31589614)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRHPR" />
          </GeneList>
          <VariantType>Deletion</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:763189</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012203.1:c.103del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_180_20230426054204</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3965444" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2021-11-29">
        <ClinVarSubmissionID localKey="d655b2eea867d18b2b34ab25cc5f917cac6d938affc3b77673d0f58f1572a787|OMIM:260000" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002024917" DateUpdated="2024-02-04" DateCreated="2021-11-29" Type="SCV" Version="3" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-12-15">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012203.2:c.103del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="260000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10694847</SubmissionName>
          <SubmissionName>SUB12926214</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2292670" SubmissionDate="2024-06-05" DateLastUpdated="2024-06-17" DateCreated="2020-02-28">
        <ClinVarSubmissionID localKey="NM_012203.2:c.103del|OMIM:260000" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001163614" DateUpdated="2024-06-17" DateCreated="2020-02-28" Type="SCV" Version="2" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-30">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012203.2:c.103del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="260000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>BG_GA_2018_SNVs_INDELS</SubmissionName>
          <SubmissionName>GA_HC_20231102_20240331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1791342" SubmissionDate="2019-02-01" DateLastUpdated="2019-05-27" DateCreated="2019-05-27">
        <ClinVarSubmissionID localKey="821243" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000916261" DateUpdated="2019-05-27" DateCreated="2019-05-27" Type="SCV" Version="1" SubmitterName="Illumina Laboratory Services, Illumina" OrgID="504895" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-11-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10484776</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15327387</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">14635115</ID>
          </Citation>
          <Comment>The GRHPR c.103delG (p.Asp35ThrfsTer11) variant results in frameshift and is predicted to result in premature termination of the protein. The p.Asp35ThrfsTer11 variant is a commonly described pathogenic variant which has been reported in at least three studies in which it was identified in at least 16 individuals diagnosed with primary hyperoxaluria, type 2. The variant was identified in a homozygous state in 14 individuals including two sets of siblings, and in a compound heterozygous state in another two individuals (Cramer et al. 1999; Cregeen et al. 2003; Rumsby et al. 2004). The variant has only been reported in individuals in Caucasian origin (Rumsby et al. 2004). The p.Asp35ThrfsTer11 variant was absent from seven controls but is reported at a frequency of 0.002111 in the African American population of the Exome Sequencing Project. The variant is also found in a homozygous state in eight individuals of the Exome Sequencing Project which could be accounted for by variable phenotypic expression from a severe early onset to asymptomatic form. Enzyme activity in patient liver biopsies has been shown to range from 0-26% of control activity (Cregeen et al. 2003; Rumsby et al. 2004). Based on the collective evidence, the c.103delG (p.Asp35ThrfsTer11) variant is classified as pathogenic for primary hyperoxaluria. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ICSL Variant Classification Criteria 09 May 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/thsgk7t4/icsl_variant_classification_criteria_09_may_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRHPR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="9" alternateAllele="T" referenceAllele="TG" start="37424858" stop="37424859" variantLength="2" />
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012203.1:c.103delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="260000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB5118208</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2354632" SubmissionDate="2020-06-18" DateLastUpdated="2020-07-03" DateCreated="2020-04-06">
        <ClinVarSubmissionID localKey="519|OMIM:260000" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001194177" DateUpdated="2020-07-03" DateCreated="2020-04-06" Type="SCV" Version="2" SubmitterName="Myriad Genetics, Inc." OrgID="507240" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <ReplacedList>
          <Replaced Accession="SCV000678189" DateChanged="2020-07-02" Version="2">
            <Comment Type="MergeComment">SCV000678189 was merged into SCV001194177 to remove duplication.</Comment>
          </Replaced>
        </ReplacedList>
        <Classification DateLastEvaluated="2019-12-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">15327387</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">18560364</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10484776</ID>
          </Citation>
          <Comment>NM_012203.1(GRHPR):c.103delG(D35Tfs*11) is classified as pathogenic in the context of type 2 primary hyperoxaluria. Sources cited for classification include the following: PMID 15327387, 18560364 and 10484776. Classification of NM_012203.1(GRHPR):c.103delG(D35Tfs*11) is based on the following criteria: The variant causes a premature termination codon that is expected to be targeted by nonsense-mediated mRNA decay and is reported in individuals with the relevant phenotype. Please note: this variant was assessed in the context of healthy population screening.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2019)</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/vlxza0ea/myriad_women_s_health_autosomal_recessive_and_x-linked_classification_criteria_2019_.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRHPR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="9" alternateAllele="T" referenceAllele="TG" start="37424858" stop="37424859" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="260000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6849778</SubmissionName>
          <SubmissionName>SUB7605676</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2873719" SubmissionDate="2020-12-28" DateLastUpdated="2021-01-02" DateCreated="2021-01-02">
        <ClinVarSubmissionID localKey="NM_012203.2:c.103delG|Primary hyperoxaluria type II" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001458444" DateUpdated="2021-01-02" DateCreated="2021-01-02" Type="SCV" Version="1" SubmitterName="Natera, Inc." OrgID="500034" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-09-16">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012203.2:c.103delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Primary hyperoxaluria type II</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB8808661</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5412685" SubmissionDate="2022-12-21" DateLastUpdated="2022-12-24" DateCreated="2022-12-24">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_012203_1_GRHPR_c_103delG" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV002767231" DateUpdated="2022-12-24" DateCreated="2022-12-24" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-05-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24116921</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss-of-function is a known mechanism of disease for this gene. (N) 0106 - This gene is known to be associated with autosomal recessive disease. (N) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (exon 2 of 9). (P) 0251 - Variant is heterozygous. (N) 0304 - Variant is present in gnomAD &lt;0.01 for a recessive condition (68 heterozygotes, 0 homozygotes). (P) 0701 - Comparable variants have very strong previous evidence for pathogenicity. (ClinVar) (P) 0801 - Strong previous evidence of pathogenicity in unrelated individuals. (ClinVar, PMID: 24116921) (P) 1102 - Strong phenotype match. (P) 1206 - Variant is paternally inherited. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRHPR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_2617</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012203.1:c.103delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0009824" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_38</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5430957" SubmissionDate="2022-12-13" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="NM_012203.2:c.103del|OMIM:260000" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002778026" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Fulgent Genetics, Fulgent Genetics" OrgID="500105" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-05">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_012203.2:c.103del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="260000" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12390657</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1835668" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2019-08-14">
        <ClinVarSubmissionID localKey="4692792|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000941720" DateUpdated="2024-02-14" DateCreated="2019-08-14" Type="SCV" Version="6" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">25644115</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10484776</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15327387</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asp35Thrfs*11) in the GRHPR gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in GRHPR are known to be pathogenic (PMID: 25644115). This variant is present in population databases (rs746720647, gnomAD 0.05%). This premature translational stop signal has been observed in individuals with primary hyperoxaluria (PMID: 10484776, 15327387). ClinVar contains an entry for this variant (Variation ID: 5636). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GRHPR" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000009.11:g.37424859del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5412685" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0009824" MappingRef="MONDO">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1394017" TraitType="Disease" MappingType="XRef" MappingValue="ORPHA93599" MappingRef="Orphanet">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1530270" TraitType="Disease" MappingType="Name" MappingValue="Nephrocalcinosis" MappingRef="Preferred">
        <MedGen CUI="C0027709" Name="Nephrocalcinosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="26172" TraitType="Disease" MappingType="Name" MappingValue="HYPEROXALURIA, PRIMARY, TYPE II" MappingRef="Preferred">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1791342" TraitType="Disease" MappingType="XRef" MappingValue="260000" MappingRef="OMIM">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="41222" TraitType="Disease" MappingType="XRef" MappingValue="C0268165" MappingRef="MedGen">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5430957" TraitType="Disease" MappingType="XRef" MappingValue="260000" MappingRef="OMIM">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="645141" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2292670" TraitType="Disease" MappingType="XRef" MappingValue="260000" MappingRef="OMIM">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1835668" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1796096" TraitType="Disease" MappingType="Name" MappingValue="Primary hyperoxaluria, type II" MappingRef="Preferred">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3965444" TraitType="Disease" MappingType="XRef" MappingValue="260000" MappingRef="OMIM">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1530270" TraitType="Finding" MappingType="Name" MappingValue="Nephrolithiasis" MappingRef="Preferred">
        <MedGen CUI="C0392525" Name="Nephrolithiasis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7327318" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="443561" TraitType="Disease" MappingType="Name" MappingValue="Primary hyperoxaluria, type II" MappingRef="Preferred">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2873719" TraitType="Disease" MappingType="Name" MappingValue="Primary hyperoxaluria type II" MappingRef="Preferred">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2354632" TraitType="Disease" MappingType="XRef" MappingValue="260000" MappingRef="OMIM">
        <MedGen CUI="C0268165" Name="Primary hyperoxaluria, type II" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

